Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Pharmaceutical Research|April 3, 2003
Limits for the scaled average bioequivalence of highly variable drugs and drug productsLaszlo Tothfalusi, Laszlo EndrenyiJournal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|May 12, 2010
Do regulatory bioequivalence requirements adequately reflect the therapeutic equivalence of modified-release drug products?Laszlo Endrenyi, Laszlo TothfalusiJournal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|January 8, 2014
Determination of bioequivalence for drugs with narrow therapeutic index: reduction of the regulatory burdenLaszlo Endrenyi, Laszlo TothfalusiInternational Journal of Clinical Pharmacology and Therapeutics|April 25, 2013
Approvable generic carbamazepine formulations may not be bioequivalent in target patient populationsLaszlo Tothfalusi, Laszlo EndrenyiJournal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|February 28, 2012
Sample sizes for designing bioequivalence studies for highly variable drugsLaszlo Tothfalusi, Laszlo EndrenyiThe AAPS Journal|February 3, 2016
An Exact Procedure for the Evaluation of Reference-Scaled Average BioequivalenceLaszlo Tothfalusi, Laszlo EndrenyiStatistics in Medicine|August 30, 2017
Algorithms for evaluating reference scaled average bioequivalence: power, bias, and consumer riskLaszlo Tothfalusi, Laszlo EndrenyiJournal of Pharmacokinetics and Pharmacodynamics|February 24, 2004
Estimation of Cmax and Tmax in populations after single and multiple drug administrationsLaszlo Tothfalusi, Laszlo EndrenyiJournal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|May 28, 2009
Regulatory and study conditions for the determination of bioequivalence of highly variable drugsLaszlo Endrenyi, Laszlo TothfalusiJournal of Pharmacokinetics and Pharmacodynamics|February 25, 2019
Bioequivalence for highly variable drugs: regulatory agreements, disagreements, and harmonizationLaszlo Endrenyi, Laszlo TothfalusiPageof 5